Imperial College London


Faculty of MedicineDepartment of Immunology and Inflammation

Professor of Haemato-oncology



+44 (0)20 3313 3237j.apperley




Miss Mandy Sale +44 (0)20 3313 4017




4N3CHammersmith HospitalHammersmith Campus






Buske C, Dreyling M, Alvarez-Larrán A, et al., 2022, Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus., Esmo Open, Vol:7

Claudiani S, Parker EL, Milojkovic D, et al., 2022, Long-term persistence of natural anti-SARS-CoV-2 antibodies and mild impact of SARS-CoV-2 infection in CML patients: results from a seroprevalence study, Leukemia & Lymphoma, ISSN:1042-8194

Dominy KM, Claudiani S, O'Hare M, et al., 2022, Assessment of quantitative polymerase chain reaction for BCR-ABL1 transcripts in chronic myeloid leukaemia: Are improved outcomes in patients with e14a2 transcripts an artefact of technology?, British Journal of Haematology, Vol:197, ISSN:0007-1048, Pages:52-62

Gallipoli P, Clark RE, Byrne J, et al., 2022, The UK SPIRIT 1 trial in newly diagnosed chronic myeloid leukaemia, British Journal of Haematology, Vol:196, ISSN:0007-1048, Pages:E55-E57

Claudiani S, Apperley JF, Parker EL, et al., 2021, Durable humoral responses after the second anti-SARS-CoV-2 vaccine dose in chronic myeloid leukaemia patients on tyrosine kinase inhibitors, British Journal of Haematology, Vol:197, ISSN:0007-1048, Pages:E1-E4

More Publications